Home > Insider Trading > Filing (0001209191-18-010119)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1610876	Jeffrey Chodakewitz	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp Gmda, Cmo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2018-02-12	1,300	$149.21	73,485	No	4	S	Direct
Common Stock	Disposition	2018-02-12	1,100	$150.47	72,385	No	4	S	Direct
Common Stock	Disposition	2018-02-12	2,022	$151.26	70,363	No	4	S	Direct
Common Stock	Disposition	2018-02-12	400	$152.62	69,963	No	4	S	Direct
Common Stock	Disposition	2018-02-12	300	$153.69	69,663	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $149.21 (range $148.80 to $149.64).
Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $150.47 (range $149.83 to $150.76).
Open market sales reported on this line occurred at a weighted average price of $151.26 (range $150.88 to $151.86).
Open market sales reported on this line occurred at a weighted average price of $152.62 (range $152.09 to $152.96).
Open market sales reported on this line occurred at a weighted average price of $153.69 (range $153.59 to $153.90).